NCT07181525View on ClinicalTrials.gov

Construction and Validation of a Predictive Model for the Efficacy of Different Biologics in Inflammatory Bowel Disease

RecruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

July 1, 2026

Study Completion Date

December 31, 2026

Conditions

Inflamatory Bowel Disease

Interventions

DRUG

anti-cytokine antibodies

Different kinds of biologics used to treat inflammatory bowel disease (including anti-cytokine antibodies)

DRUG

anti-integrin antibodies

Different kinds of biologics used to treat inflammatory bowel disease (including anti-integrin antibodies)

Trial Locations (1)

Unknown

RECRUITING

Peking University First Hospital, Beijing

All Listed Sponsors

lead

Peking University First Hospital

OTHER

NCT07181525 - Construction and Validation of a Predictive Model for the Efficacy of Different Biologics in Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter